Our additional preliminary studies demonstrate that dual targeting of multiple myeloma cells and BM-CAFs by CAR-T cells is ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...

Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to fight ...

To improve long-term persistence and reduce the risk of immune rejection, researchers are exploring ways to diminish the ...

Liver failure encompasses a range of severe clinical syndromes resulting from the deterioration of liver function, triggered ...

The CAR-T cell therapy Aucatzyl was approved for relapsed or refractory B-cell precursor acute lymphoblastic leukemia based ...

A novel test developed by Duke-NUS researchers enables real-time monitoring of T cells that have been engineered to ...

Cullinan will present new in vitro preclinical data that provide further strong rationale for broad clinical development of ...